Curis (CRIS) Current Assets (2010 - 2026)
Curis' (CRIS) quarterly Current Assets came in at $16.6 million in Q1 2026, down 33.05% YoY from $24.8 million in Q1 2025, and up 140.22% on a QoQ basis from $6.9 million in Q4 2025.
Curis (CRIS) Current Assets (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Current Assets data on file, last reported at $16.6 million in Q1 2026.
- Quarterly Current Assets fell 33.05% year-over-year to $16.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (down 33.05% YoY) and the FY2025 annual result came in at $6.9 million, down 73.79% from the prior year.
- Current Assets grew to $16.6 million in Q1 2026, from $6.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $126.1 million in Q1 2022 to a low of $6.9 million in Q4 2025.
- A 5-year average of $54.6 million and a median of $46.1 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets declined 21.66% — and 2025, when it sank 73.79%.
- Tracing CRIS's Current Assets over 5 years: stood at $92.1 million in 2022, then sank by 33.88% to $60.9 million in 2023, then sank by 56.68% to $26.4 million in 2024, then slumped by 73.79% to $6.9 million in 2025, then jumped by 140.22% to $16.6 million in 2026.
- The last three Current Assets figures came in at $16.6 million (Q1 2026), $6.9 million (Q4 2025), and $13.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 1.76 Bn |
| 10 | Curis | 3.46 Mn | -2.16 Mn | - | 6.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.61 Mn |
| Dec 31, 2025 | 6.92 Mn |
| Sep 30, 2025 | 13.91 Mn |
| Jun 30, 2025 | 14.42 Mn |
| Mar 31, 2025 | 24.81 Mn |
| Dec 31, 2024 | 26.39 Mn |
| Sep 30, 2024 | 26.94 Mn |
| Jun 30, 2024 | 34.52 Mn |
| Mar 31, 2024 | 46.07 Mn |
| Dec 31, 2023 | 60.91 Mn |
| Sep 30, 2023 | 73.43 Mn |
| Jun 30, 2023 | 67.85 Mn |
| Mar 31, 2023 | 78.01 Mn |
| Dec 31, 2022 | 92.12 Mn |
| Sep 30, 2022 | 105.72 Mn |
| Jun 30, 2022 | 113.40 Mn |
| Mar 31, 2022 | 126.14 Mn |
| Dec 31, 2021 | 122.38 Mn |
| Sep 30, 2021 | 134.95 Mn |
| Jun 30, 2021 | 156.53 Mn |